Skip to main content

Table 1 Correlation between circNOL10 expression and clinicopathological features in 60 breast cancer patients

From: CircNOL10 suppresses breast cancer progression by sponging miR-767-5p to regulate SOCS2/JAK/STAT signaling

Variable

circNOL10 expression

P value

Low (n = 30)

High (n = 30)

 

Age

  

0.573

 ≤ 50

10

8

 

 > 50

20

22

 

Tumor size

  

0.018*

 < 2 cm

8

17

 

 ≥ 2 cm

22

13

 

TNM stage

  

0.007*

 I–II

14

24

 

 III–IV

16

6

 

Lymph node metastasis

  

0.038*

 Negative

10

18

 

 Positive

20

12

 

Menopausal

  

0.438

 Premenopausal

16

13

 

 Postmenopausal

14

17

 

ER status

  

0.432

 Negative

19

16

 

 Positive

11

14

 

PR status

  

0.592

 Negative

10

12

 

 Positive

20

18

 

HER-2 status

  

0.584

 Negative

9

11

 

 Positive

21

19

 
  1. The median expression level of circNOL10 was used as the cutoff
  2. P < 0.05 was considered as statistically significant